This launch follows the nod from the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA), making Biocon the ...

Sara Burnett, executive director of non-profit ReFED, on food waste in the US, government policies, and the impact of AI and ...

Biocon announced the launch of its GLP-1 peptide, Liraglutide, for diabetes and obesity, in the United Kingdom (U.K.). The drug-device combination will be marketed in the U.K. under the brand names ...

Biocon has announced the launch of its GLP-1 peptide Liraglutide for diabetes and obesity in the United Kingdom (U.K.).

Companies such as PepsiCo and Mondelēz haven’t seen an impact on business, while Healthy Choice maker Conagra sees the ...

If you’re a Queer Eye fan, then you know and love Jonathan Van Ness, the show’s bubbly hairstylist known to share their words ...

Jim Salera, a restaurant, packaged-food, and beverage analyst at Stephens, likes Celsius Holdings, Wingstop, and other names.

ACCESS and ACCESS II studies fully enrolled; topline data from both studies anticipated by year-end 2025Oral small ...

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a ...

Outsourcing Facilities Association and North American Custom Laboratories allege the FDA removed semaglutide from its ...